Educational research & price index · Independent Janoshik & MZ Biolabs COA verification

← Verified COAs & $/mg for this compound

Guide|25 CitationsCosmetic & SkinFemale-friendly

GHK-Cu (Copper Peptide) Research Dosing Reference

Also known as: Copper Tripeptide-1, Gly-His-Lys-Cu2+, Collagen & Skin Peptide

Dose Range
1–2 mgResearch range
0Typical research window: 1–2 mg3 mg

Studied in human skin-remodeling & wound healing studies. Injectable protocols typically use 1–2 mg daily from a 50 mg or 100 mg vial.

Protocol at a Glance
How Often
Daily

Once daily SubQ (or topical 1–2% serum)

A Typical Run
6–12 weeks

Typically run 6–8 weeks on followed by 2–4 weeks off; often paired with BPC-157.

How It's Taken
Vial / Topical

SubQ injection or topical cosmetic serum

Evidence
Clinical Trials

Human dermal clinical studies & Pickart gene-expression data

Half-Life & 72-Hour Clearance Shape
Not established in humans

Not established in humans; no published human pharmacokinetic data

0h18h36h54h72h
On Your SyringeU-100 Insulin Syringe

A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.

50 mg vial · 3 mL water · 0.3 mL syringe
Concentration: 16.67 mg in every mL (167 mcg per unit)
0u6u12u18u24u30u
Low end: 1 mg6 units
High end: 2 mg12 units

All U-100: 100 units = 1 mL. 50 doses in the vial at the low end (25 doses at the high end).

Track the doses you run

Save GHK-Cu (Copper Peptide) to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.

Verified Peptide Vial Suppliers · Sorted by Real $/mg•Checked Nov 11, 2026

GHK-Cu (Copper Peptide) supplier & $/mg comparison.

Source:
Max $/mg:
Sort:
Ascension Peptides50% OFF AUTO-APPLIED
Batch COAs (Kovera Labs, MZ Biolabs) on product page
US Domestic Vial
50% Off First Order Link
$29.50 net$59.00
100mg Lyophilized Vial
$0.29/mg$0.59/mg retail
Peptyes
Horizon Analytical UPLC-MS COA, lot DPS-6133020 (99.62%); COA names Privilege Bio Labs (Peptyes says: its manufacturer)
US Domestic Vial
List price (verified Nov 11, 2026); code PEPTIDEPROTOCOLS takes 10% off at checkout
$48.00
100mg vial
$0.48/mg
Ameano Peptides
Batch COA portal on store site
US Domestic Vial
List price (verified Oct 30)
$53.00
100mg vial
$0.53/mg
Swift Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$54.99
100mg vial
$0.55/mg
Bulletproof BioLabs
ILS Laboratories HPLC COA COA-2026-QZ4BWH, lot BPB-2610-001
US Domestic Vial
Vendor-supplied list price (Nov 7, 2026; store requires login)
$60.00
100mg vial
$0.60/mg
Protide Health
Per-lot COA (Freedom Diagnostics, HPLC-MS) on product page
US Domestic Vial
List price
$65.00
100mg vial
$0.65/mg
Pure Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026); code PEPTIDE9544 takes 10% off at checkout
$69.00
100mg vial
$0.69/mg
Polaris Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$35.00
50mg vial
$0.70/mg
Elite Research USA
Batch COA on product page
US Domestic Vial
List price
$40.00
50mg vial
$0.80/mg
Biotech Peptides
COA per store product page
US Domestic Vial
List price (verified Oct 31)
$186.00
200mg vial
$0.93/mg
Core Peptides
COA per store product page
US Domestic Vial
List price (verified Oct 31)
$197.00
200mg vial
$0.98/mg
Direct Peptides
COA per store product page
US Domestic Vial
List price (last verified Nov 4, 2026; store now requires sign-in)
$49.00
50mg vial
$0.98/mg
Healius Peptides
Third-party HPLC COA on product page, lot HP2517096211-50 (99.66% HPLC)
US Domestic Vial
Current USD price (store sale vs regular $74.95; no partner coupon; verified Nov 10, 2026)
$64.95$74.95
50mg lyophilized vial (29 in stock)
$1.30/mg$1.50/mg retail
SwissChems
Independent test results linked on store
US Domestic Vial
Verified Partner Link
$68.95
50mg Lyophilized Vial
$1.38/mg
Limitless Peptides
COA per store product page
US Domestic Vial
Code: PEPTIDEPROTOCOLS
$150.00
100mg vial
$1.50/mg
BioLongevity Labs
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$84.97
50mg vial
$1.70/mg
Sorted strictly by calculated $/mg or 2026 COA score. Only research peptide vial suppliers are included in $/mg benchmarks.
Full Verified $/mg Index →

At a Glance · 2026 FDA / 503A / WADA / Evidence Profile

2026 FDA 503A Cat-2 UpdateTier 2 — Human Phase 1/2 Clinical Data
Pharmacological Class
Synthetic Bioactive Signaling Peptide
Administration Route
Topical serum/foam (0.5%–2% dermal/scalp) or Under-the-skin injection (SubQ systemic)
2026 FDA & 503A Status
Not FDA-approved. In April 2026, the FDA removed 14 peptides (including BPC-157, Thymosin Beta-4/TB-500, CJC-1295, Ipamorelin, AOD-9604, Semax, Selank, and DSIP) from the Category 2 503A Interim Bulks List pending formal July 2026 PCAC rulemaking. Available as COA-verified research reference standards or via specialized physician telehealth guidance.
WADA Sport Status
Not explicitly listed on WADA Prohibited List (Topical/nutritional use permitted; IV infusions >100 mL/12h prohibited under M2.2)
Evidence Tier
Tier 2 — Human Phase 1/2 Clinical Data: Published human Phase 1/2 clinical studies, regional regulatory approval, or controlled human biomarker trials
What is a Peptide?

A short chain of amino acids (2-50) linked by peptide bonds. Smaller than proteins. Your body produces thousands of peptides naturally as signaling molecules that regulate everything from appetite to healing. Therapeutic peptides mimic or enhance these natural signals.

Bottom Line Up Front

GHK-Cu is a naturally occurring copper peptide that declines with age. It promotes wound healing, collagen synthesis, and has antioxidant properties. Discovered by Dr. Loren Pickart in 1973. Well-studied for skin aging and wound repair.

Best evidence for

Skin aging, wound healing, collagen synthesis

Weakest evidence for

Systemic anti-aging, hair growth

Pharma equivalent

None

Studies on file

25 (15 human)

EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. GHK-Cu (Copper Peptide) is not FDA approved for human use (unless specified above). This information does not constitute medical advice.

Overview

GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. It has been extensively studied for tissue repair, skin regeneration, and anti-aging effects.

Mechanisms of Action

  • Promotes collagen synthesis
  • Enhances wound healing
  • Regulates copper metabolism
  • Anti-inflammatory properties

Research Protocols

Summaries of published research. For educational purposes only.

Protocol NameSourceDoseFrequencyDurationRouteEvidenceLinkSave
Skin Regeneration Study
published study
2% topicalTwice daily12 weeksTopicalhuman
Baseline & Mid-Cycle Biomarker Bloodwork Panel

Systemic Inflammation, Tissue Repair & Immune Biomarker Panel (GHK-Cu (Copper Peptide))

Objective inflammatory, hematologic, and trace-mineral markers to quantify connective-tissue recovery, cytokine resolution, and organ safety.

Draw fasted morning labs at Baseline (Day 0) and Mid-Cycle (Week 6–8)

hs-CRP (High-Sensitivity C-Reactive Protein)

Day 0 + Wk 6–8

Why track at baseline: Quantifies baseline systemic IL-6/NF-κB inflammatory burden from tendon, joint, gut, or vascular injury.

Week 6–8 check: Target <1.0 mg/L (optimal <0.5 mg/L) by Week 6–8 as tissue inflammation resolves.

ESR (Sedimentation Rate) & Ferritin

Day 0 + Wk 6–8

Why track at baseline: Tracks chronic connective-tissue and autoimmune/mucosal inflammatory activity alongside iron stores.

Week 6–8 check: Downward trend in ESR confirming structural resolution rather than temporary analgesic masking.

CBC with Differential (WBC, Neutrophil/Lymphocyte Ratio)

Day 0 + Wk 6–8

Why track at baseline: Evaluates innate/adaptive immune balance (especially for Thymosin Alpha-1, Thymosin Beta-4, LL-37 & KPV).

Week 6–8 check: Balanced lymphocyte count and improved Neutrophil-to-Lymphocyte Ratio (NLR 1.2–2.0).

CMP (Liver/Kidney) + Serum Copper & Zinc Ratio

Day 0 + Wk 6–8

Why track at baseline: Verifies baseline hepatic/renal function and checks Copper:Zinc balance before GHK-Cu / GLOW / KLOW protocols.

Week 6–8 check: Maintain 1:1 to 1.2:1 Zinc-to-Copper equilibrium and normal transaminases/creatinine.

Test before and during your protocol: one baseline panel of 100+ Quest biomarkers covering the markers above, plus a mid-cycle retest. No doctor visit required.Code SPAMBASSADOR
Get baseline bloodwork at Superpower

Related Studies

15 Human10 Animal

Although preclinical studies are promising, there is a current lack of clinical trials. This review integrates current mechanistic insights with orthopaedic relevance, emphasizing safety, efficacy, and future directions for responsible integration into musculoskeletal care.

Limitations: No placebo control reported. Review article — no new primary data.

2026|Journal of the American Academy of Orthopaedic Surgeons. Global research &amp; reviews
PubMed

BPC-157 demonstrated potential benefits in tendon and muscle repair, but these findings are largely unvalidated in human trials. A single human case series reported improvements in pain after intra-articular knee injections of BPC-157, although significant methodological flaws and a lack of controls limit its applicability and reliability.

Limitations: No placebo control reported. Review article — no new primary data.

2026|The American journal of sports medicine
PubMed

Based on cellular studies, undoubtedly, GHK can be considered as an anti-wrinkle ingredient. Although GHK-Cu and Pal-GHK have been of interest as effective peptides to be incorporated in the anti-wrinkle products, there is a surprising absence of clinical studies using them.

Limitations: Animal study only — human translation uncertain. Review article — no new primary data.

2025|BioImpacts : BI
PubMed

These peptide derivatives behave as copper ionophores, utilizing Cu2+ present in the culture medium; also, an increase in the metal intracellular level occurs with a consequent stimulation of the copper-driven signaling pathways that produce the expression/release of trophic (Brain-Derived Neurotrophic Factor, BDNF, and Bone Morphogenetic Protein 2, BMP-2) and angiogenic (Vascular Endothelial Growth Factor, VEGF) proteins. Copper chaperons for SOD1, CCS, and Antioxidant 1 (Atox-1) are the copper chaperones that act as transcription factors.

Limitations: Animal study only — human translation uncertain. Review article — no new primary data.

2025|Antioxidants (Basel, Switzerland)
PubMed

The results highlight copper's role in promoting the expression and release of certain trophic, angiogenic, and osteogenic factors, including brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF), as well as bone morphogenetic protein-2 (BMP-2). The protective and regenerative activities of the metal ion are related to the translocation of its intracellular chaperones Copper Chaperone for Superoxide Dismutase (CCS) and Antioxidant-1 (Atox1) to the nucleus where they act as transcription factors.

Limitations: No placebo control reported.

2025|Bioconjugate chemistry
PubMed

An analysis of the literature data reveals that the transport of liposomes containing GHK-Cu received little attention. This research gap gives an impetus to the methodological developments for assessing the effect of liposomes on GHK-Cu transportation and trafficking.

Limitations: No placebo control reported. Review article — no new primary data.

2025|Molecules (Basel, Switzerland)
PubMed

GHK-Cu alleviated weight loss, improved the disease activity index (DAI), reduced colonic edema and shortening, attenuated inflammatory damage, increased goblet cell numbers, suppressed inflammatory cytokines such as TNF-&#x3b1;, IL-6, and IL-1&#x3b2;, and promoted mucosal repair. Additionally, a co-culture system of MCECs and MPMs revealed that GHK-Cu facilitated MCECs healing, impaired by DSS, by upregulating ZO-1 and Occludin expression.

Limitations: Animal study only — human translation uncertain.

2025|Frontiers in pharmacology
PubMed

In this process, H&E staining and Masson staining revealed significant collagen deposition. These findings further confirm that GHK-Cu@CMHA is a novel injectable soft tissue filler with good anti-inflammatory and antioxidant properties, which holds well potential for inflammation inhibition.

Limitations: Animal study only — human translation uncertain.

2025|Colloids and surfaces. B, Biointerfaces
PubMed

In addition, preliminary observations suggest GHK can partially reverse cognitive impairment in aging mice by targeting anti-inflammatory and epigenetic pathways. The evidence as presented provides the rationale to further investigate this naturally occurring peptide in preclinical and clinical aging studies.

Limitations: Animal study only — human translation uncertain. Preliminary/pilot study — needs larger trials.

2024|Aging pathobiology and therapeutics
PubMed

Thus, our results suggest that GHK-Cu acts as a potential drug by attenuating alveolar macrophage oxidative stress. This, in turn, attenuates the progression of pulmonary inflammation and fibrosis, which provides a reference for the treatment of silicosis.

Limitations: No placebo control reported.

2024|Redox biology
PubMed

Finally, we investigated the effects of copper on enhancing paraquat toxicity and report a protective effect of GHK. We therefore conclude that GHK has potential as a cytoprotective compound with regard to copper and zinc toxicity, with positive effects on protein solubility and aggregation that warrant further investigation in the treatment of neurodegenerative diseases.

Limitations: No placebo control reported.

2024|Metallomics : integrated biometal science
PubMed

Compared with healthy control, plasma GHK levels were decreased in patients with COPD (70.27&#xa0;&#xb1;&#xa0;38.87&#xa0;ng/mL vs. 133.0&#xa0;&#xb1;&#xa0;54.54&#xa0;ng/mL, P&#xa0;=&#xa0;0.009).

Limitations: No placebo control reported.

2023|Journal of cachexia, sarcopenia and muscle
PubMed

This study provided a useful method for induced production of laccase by applying GHK chelated metal ion as a non-toxic inducer, which reduced the safety risk of laccase broth and provided the potential application of crude laccase in food industry. In addition, GHK can be used as the carrier of different metal ions to enhance the production of other metalloenzymes.

Limitations: Animal study only — human translation uncertain.

2023|Frontiers in bioengineering and biotechnology
PubMed

Collectively, decreased plasma GHK levels were related to FAO in asthma patients. Through the direct binding and activation of SIRT1, exogenous GHK-Cu administration alleviated airway remodeling in asthmatic mice.

Limitations: No placebo control reported.

2023|Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
PubMed

GHK-Cu treatment attenuated the CS-induced emphysematous changes and partially reversed the matrix metalloprotein -9 (MMP-9)/tissue inhibitor of metalloproteinases-1 (TIMP-1) imbalance in the lung tissue. GHK-Cu reduced the inflammation and oxidation by decreasing the expression of inflammatory cytokines (IL-1&#x3b2; and TNF-&#x3b1;) in the bronchoalveolar lavage and the enzymatic activity of MPO and MDA in the lung homogenate while restoring the T-AOC and GSH content.

Limitations: Animal study only — human translation uncertain.

2022|Frontiers in molecular biosciences
PubMed

We identified His3 as one site of ternary complex formation (conditional binding constant cKCu(GHK)NImHis3Cu(GHK) = 2900 M-1 at pH 7.4), with the second site (cKCu(GHK)NImHisXCu(GHK) = 1700 M-1) likely being supplied by either His128 or His510. Together with the established role of HSA as a molecular shuttle in the blood, these complexes may aid the transport of the exchangeable Cu2+ pool and the functional form of GHK.

Limitations: Preliminary/pilot study — needs larger trials. No placebo control reported.

2022|Inorganic chemistry
PubMed

Additionally, the GHK effect on the signal of &#xb7;OH was much stronger than those of other well-known antioxidative, endogenous peptides, carnosine and reduced glutathione. These results suggest that GHK can function as an endogenous antioxidant in living organisms, possibly by diminishing &#xb7;OH and ROO&#xb7;.

Limitations: Animal study only — human translation uncertain.

2020|International journal of physiology, pathophysiology and pharmacology
PubMed

GHK has also been found to possess powerful cell protective actions, such as multiple anti-cancer activities and anti-inflammatory actions, lung protection and restoration of chronic obstructive pulmonary disease (COPD) fibroblasts, suppression of molecules thought to accelerate the diseases of aging such as NF&#x3ba;B, anti-anxiety, anti-pain and anti-aggression activities, DNA repair, and activation of cell cleansing via the proteasome system. Recent genetic data may explain such diverse protective and healing actions of one molecule, revealing multiple biochemical pathways regulated by GHK.

Limitations: No placebo control reported. Review article — no new primary data.

2018|International journal of molecular sciences
PubMed

It is capable of up- and downregulating at least 4,000 human genes, essentially resetting DNA to a healthier state. The present review revisits GHK's role in skin regeneration in the light of recent discoveries.

Limitations: No placebo control reported. Review article — no new primary data.

2016|BioMed research international
PubMed

Recent studies revealed its ability to up- and downregulate a large number of human genes including those that are critical for neuronal development and maintenance. We propose GHK tripeptide as a possible therapeutic agent against age-associated neurodegeneration and cognitive decline.

Limitations: No placebo control reported. Review article — no new primary data.

2012|Oxidative medicine and cellular longevity
PubMed

GHK-Cu also improves hair transplant success, protects hepatic tissue from tetrachloromethane poisoning, blocks stomach ulcer development, and heals intestinal ulcers and bone tissue. These results are beginning to define the complex biochemical processes that regulate tissue remodeling.

Limitations: No placebo control reported. Review article — no new primary data.

2008|Journal of biomaterials science. Polymer edition
PubMed

Taken together, our results underline that GHK-Cu is not only an activator of connective tissue production but also of the remodeling of the extracellular matrix. It is able to modulate MMP expression by acting directly on wound fibroblasts.

Limitations: Animal study only — human translation uncertain.

2000|Life sciences
PubMed

In contrast to its effect on cell attachment, GHK:Cu coating slightly inhibited the basal and 1,25(OH)2D-induced stimulation of ALP activity or osteocalcin production in rat and human osteoblastic cells. The finding that GHK promotes cell attachment and decreases the phenotype of normal rat and human osteoblastic cells suggests that osteoblasts may interact with free GHK or GHK-containing proteins in the bone matrix.

Limitations: No placebo control reported.

1996|Cellular and molecular biology (Noisy-le-Grand, France)
PubMed

(1980) Nature (London) 288, 715-717; C. Pickart, unpublished results], does not exist in solution.

Limitations: Animal study only — human translation uncertain.

1983|Biochemistry
PubMed

This distribution could be due to the binary as well as the ternary complexes. The possible physiological role of these complexes in the transportation of Cu(II) from blood to tissues is discussed.

Limitations: No placebo control reported.

1982|The Biochemical journal
PubMed

Community Outcomes

Community Data Coming Soon

Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!

Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.

Important Warnings

  • •Generally well-tolerated topically
  • •Copper balance considerations
Sourcing, Diagnostic Bloodwork & Telehealth Pathways

Where to get GHK-Cu (Copper Peptide), baseline labs & clinician oversight.

Full GHK-Cu (Copper Peptide) $/mg comparison →
50% OFF AUTO-APPLIED$0.29/mg net

Ascension Peptides (US Vials)

MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.

MZ Biolabs COA (Grade A)Claim 50% Off
Verified Vial Suppliers$1.38/mg

SwissChems & Limitless Biotech

Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).

LABS & 503A CLINICS$199/yr Labs · Rx Consult

Superpower Labs & 503A Telehealth

Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.

Code:SPAMBASSADOR

Where to buy GHK-Cu (Copper Peptide): best verified price

Prices checked Nov 11, 2026 · sorted by $/mg · RUO

  1. 1. Ascension Peptides — $0.29/mg (100mg Lyophilized Vial, $29.50)
  2. 2. Peptyes — $0.48/mg (100mg vial, $48.00)
  3. 3. Ameano Peptides — $0.53/mg (100mg vial, $53.00)

Where is the cheapest place to buy GHK-Cu (Copper Peptide)?

As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Ascension Peptides at $0.29/mg (100mg Lyophilized Vial, $29.50 after the 50% new-customer partner-link discount). We compared 16 US suppliers with live, checked prices.

How much does GHK-Cu (Copper Peptide) cost per mg?

Verified US domestic prices currently range from $0.29/mg to $1.70/mg depending on supplier and vial size. Larger vials usually lower the $/mg.

How are these prices verified?

Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.

Is GHK-Cu (Copper Peptide) approved for human use?

Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.

All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet

FREE 1-PAGE PDF CHEAT SHEET

Peptide Reconstitution & U-100 Syringe Cheat Sheet

Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.

Unsubscribe anytime.Direct PDF Download

Related Peptides

Popular Stacks

Vendor vs vendor: price per mg

Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.

Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →

Common questions

How many peptides are in the database?

100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.

Where can I compare peptide prices?

Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.